Regeneron Pharmaceuticals Current Ratio 2010-2024 | REGN

Regeneron Pharmaceuticals current ratio for the quarter ending September 30, 2024 was 5.28.

  • Regeneron Pharmaceuticals average current ratio for 2023 was 5.44, a 7.09% decline from 2022.
  • Regeneron Pharmaceuticals average current ratio for 2022 was 5.08, a 45.56% increase from 2021.
  • Regeneron Pharmaceuticals average current ratio for 2021 was 3.49, a 0.87% increase from 2020.

Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.

Regeneron Pharmaceuticals Current Ratio 2010-2024 | REGN

  • Regeneron Pharmaceuticals average current ratio for 2023 was 5.44, a 7.09% decline from 2022.
  • Regeneron Pharmaceuticals average current ratio for 2022 was 5.08, a 45.56% increase from 2021.
  • Regeneron Pharmaceuticals average current ratio for 2021 was 3.49, a 0.87% increase from 2020.

Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.